China's CSPC Pharma partners with Pfizer for COVID oral treatment
Chinese pharma major CSPC Pharmaceutical Group said on Thursday it has signed a strategic partnership with Pfizer to launch a local brand of a COVID-19 oral therapeutic treatment in China.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.